Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
Fiona Robinson, Consultant, Medical Writing and Editing, at Communications Fiona Robinson, reposted from National Bleeding Disorders Foundation on LinkedIn:
”Rebalancing agents are now a treatment option for some bleeding disorders – but what exactly are rebalancing agents?
What do people with bleeding disorders and their caregivers need to know about them?
In the next National Bleeding Disorders Foundation Wednesday Webinar we will hear from medical, research, and lived experience experts about how they consider this exciting new class of therapeutics in their shared decision-making to choose the best options for their unique needs?
June 3, 2PM ET
Bring your questions for the live QandA!”
Quoting National Bleeding Disorders Foundation‘s post:
”Rebalancing Agents and You: Partnering in Treatment Decisions
Join NBDF and expert clinicians to learn about rebalancing agents, a new class of therapies for bleeding disorders.
This session will help patients and caregivers understand how these treatments work, what to expect, and how to engage in shared decision-making with their care team to choose the best options for their unique needs.”
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection